HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Clinical trials for HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN explained in plain language.
Never miss a new study
Get alerted when new HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN trials appear
Sign up with your email to follow new studies for HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough drug trial aims to stop devastating blood disease in unborn babies
Disease control Recruiting nowThis study is testing an investigational drug called nipocalimab to see if it can prevent severe fetal anemia in pregnant women at high risk for a serious blood condition called Hemolytic Disease of the Fetus and Newborn (HDFN). The goal is to help babies avoid dangerous complica…
Matched conditions: HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Tracking blood disease risks in unborn babies worldwide
Knowledge-focused Recruiting nowThis study is creating a global registry to track pregnancies at risk for hemolytic disease of the fetus and newborn (HDFN), a blood condition where a mother's and baby's incompatible blood types cause rapid red blood cell breakdown. Researchers will follow 175 pregnant participa…
Matched conditions: HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC